ValuentumAd

Official PayPal Seal
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Mar 11, 2017
Celgene: A Hemeoncology Powerhouse
Let’s walk through the investment merits of one of the market darlings in biotech.
Mar 10, 2017
Priceline Delivers on Bookings Strength, Free Cash Flow Growth
Best Ideas Newsletter portfolio holding Priceline finished 2016 on a high note. Let’s take a quick look at its fourth-quarter report.
Mar 2, 2017
Dow 21,000+; Forward P/E on S&P 500 ~18!!!
To say that the broader equity market is “extended” is an understatement.
Feb 14, 2017
#14? You Can’t Control The Market
Image shown: Wall Street Journal front pages from the Financial Crisis -- a reminder that an investor cannot control the markets. Should this be added to the “13 Steps…” piece?
Feb 13, 2017
Dividend Increases/Decreases for the Week Ending February 10
Let's take a look at the companies that raised/lowered their dividends this week.
Feb 11, 2017
Best Ideas Roundup: Visa, Facebook, Buffalo Wild Wings
Image Source: DeclanTM. Let’s take a look at the recent earnings reports and outlooks for three key holdings in the Best Ideas Newsletter portfolio.
Feb 1, 2017
Consumer Staples: Product Pricing Gains To Wane in 2017?
Consumer staples giants Kimberly-Clark and Colgate-Palmolive are expecting product pricing growth to be less of a contributor in 2017.
Jan 27, 2017
Microsoft's Fantastic Free Cash Flow; LinkedIn Deal Completed
Image Source: Microsoft. Microsoft completed its acquisition of social media platform LinkedIn during the course of the second quarter of its fiscal 2017. Otherwise, it was business as usual for the software giant.
Jan 26, 2017
Boeing’s Lift Off, Lockheed’s Caution, and United Tech’s Outlook
Image Source: Rob Buhlman. Just how healthy is the commercial aerospace market? Very -- if the size of Boeing’s backlog is any indication. Let’s have a look.
Jan 25, 2017
Placing Meridian Bioscience Under Review
We are placing Meridian Bioscience's fair value estimate and Dividend Cushion ratio under review as we assess its fiscal 2017 outlook. Please expect an updated 16-page report and dividend report shortly.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.